Postcodes still determine how quickly drugs reach patients: Europe’s cancer chief

EU PERSPECTIVES - A cancer treatment can clear Europe-wide approval, yet patient access still varies enormously from one country to the next. The difference is as much as three years, Isabel Rubio, the president of the European Cancer Organisation tells EU Perspectives. Read more

Europe's cancer gap comes down to people, not science: Isabel Rubio, president of the European Cancer Organisation / Photo: European Cancer Organisation